NasdaqCM - Delayed Quote • USD
BeyondSpring Inc. (BYSI)
At close: April 23 at 4:00 PM EDT
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,550.0000
1,351.0000
1,351.0000
180.0000
Operating Expense
31,465.0000
38,590.0000
67,591.0000
64,391.0000
Operating Income
-29,915.0000
-37,239.0000
-66,240.0000
-64,211.0000
Net Non Operating Interest Income Expense
435.0000
178.0000
11.0000
31.0000
Other Income Expense
-32.0000
944.0000
1,591.0000
359.0000
Pretax Income
-29,512.0000
-36,117.0000
-64,638.0000
-63,821.0000
Tax Provision
-135.0000
163.0000
3,570.0000
--
Net Income Common Stockholders
-27,510.0000
-33,279.0000
-64,179.0000
-60,973.0000
Diluted NI Available to Com Stockholders
-27,510.0000
-33,279.0000
-64,179.0000
-60,973.0000
Basic EPS
-0.71
--
-1.64
-2.03
Diluted EPS
-0.71
--
-1.64
-2.03
Basic Average Shares
39,048.7720
--
39,023.6430
29,984.2840
Diluted Average Shares
39,048.7720
--
39,023.6430
29,984.2840
Total Operating Income as Reported
-29,915.0000
-37,239.0000
-66,240.0000
-64,211.0000
Total Expenses
31,465.0000
38,590.0000
67,591.0000
64,391.0000
Net Income from Continuing & Discontinued Operation
-27,510.0000
-33,279.0000
-64,179.0000
-60,973.0000
Normalized Income
-27,232.2763
-32,940.0900
-64,347.6300
-61,328.0000
Interest Income
435.0000
195.0000
98.0000
116.0000
Interest Expense
--
17.0000
87.0000
85.0000
Net Interest Income
435.0000
178.0000
11.0000
31.0000
EBIT
-29,512.0000
-36,100.0000
-64,551.0000
-63,736.0000
EBITDA
-29,512.0000
-35,868.0000
-64,490.0000
-63,659.0000
Reconciled Depreciation
--
232.0000
61.0000
77.0000
Net Income from Continuing Operation Net Minority Interest
-27,510.0000
-33,279.0000
-64,179.0000
-60,973.0000
Total Unusual Items Excluding Goodwill
-279.0000
-429.0000
231.0000
355.0000
Total Unusual Items
-279.0000
-429.0000
231.0000
355.0000
Normalized EBITDA
-29,233.0000
-35,439.0000
-64,721.0000
-64,014.0000
Tax Rate for Calcs
0.0000
0.0002
0.0003
--
Tax Effect of Unusual Items
-1.2763
-90.0900
62.3700
--
12/31/2020 - 3/9/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BIVI BioVie Inc.
0.4918
+1.78%
PSTV Plus Therapeutics, Inc.
1.6300
-0.61%
ALLO Allogene Therapeutics, Inc.
3.3700
-0.88%
BCAB BioAtla, Inc.
2.2400
+2.75%
NEXI NexImmune, Inc.
3.4300
-5.90%
AUPH Aurinia Pharmaceuticals Inc.
5.09
+0.79%
NBSE NeuBase Therapeutics, Inc.
0.4210
+2.43%
BTAI BioXcel Therapeutics, Inc.
2.9700
+4.21%
IMRX Immuneering Corporation
1.6300
-5.23%
QNCX Quince Therapeutics, Inc.
1.1100
+4.72%